SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001860782-22-000011
Filing Date
2022-04-08
Accepted
2022-04-08 16:17:07
Documents
14
Period of Report
2022-04-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20220408.htm   iXBRL 8-K 36098
2 EX-99.1 ex991bbt369aacrpressrelease.htm EX-99.1 25860
6 image_0a.jpg GRAPHIC 31087
  Complete submission text file 0001860782-22-000011.txt   253568

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20220408.xsd EX-101.SCH 2008
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20220408_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20220408_pre.xml EX-101.PRE 13142
8 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20220408_htm.xml XML 11626
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 22817211
SIC: 2834 Pharmaceutical Preparations